stars 1 stars 2 stars 3

Accelerate Clinical Trials with Diverse Expertise and Global Reach TASK: Your Partner for Efficient, High-Quality Clinical Research TASK is a leading multinational, multi-site clinical research institute (CRI) dedicated to expediting the development of novel medicines, vaccines, and diagnostics. We offer comprehensive services for sponsors and CROs, from Phase I to IV trials across various therapeutic areas. Our unique advantages: Global Reach: Leverage our dedicated Phase I unit in Utrecht, Netherlands, in collaboration with UMC Utrecht, alongside our 6 clinical sites strategically located in Western Cape, South Africa. Cost-Effective and Time-Conscious: Benefit from our commitment to delivering efficient and timely trials with accurate data. Extensive Experience: Global Collaboration: Since 2005, we've successfully completed over 100 projects, collaborating with leading international sponsors, CROs, and consortiums across a diverse range of therapeutic areas. We are currently proud to be a partner in the largest Tuberculosis (TB) consortium globally, working towards the development of a new TB treatment regimen. This extensive experience and global network position us to deliver exceptional value for your clinical trials. Partner with TASK to: Expedite clinical development timelines Access diverse patient populations Reduce trial costs Gain access to a team of experienced professionals Contact us today to discuss your next clinical trial.

TASK Questions

The TASK annual revenue was $13.8 million in 2026.

19 people are employed at TASK.

TASK is based in Cape Town, Western Cape.

The NAICS codes for TASK are [54, 5417, 541].

The SIC codes for TASK are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users